TB-500, KPV, GHK-Cu, and AOD-9604 are not FDA-approved for human use in any form
However, he stresses the importance of being cautious, especially if you have polyps or are at risk for developing cancer due to the peptide's effects on developing new blood vessels and highlights that while there's no clear evidence of BPC-157 supporting cancerous tissue growth, the potential should not be completely disregarded 3
The theoretical advantage of cagrilintide plus retatrutide is the additional GIP and glucagon receptor activation, which should translate to greater energy expenditure and fat metabolism
"That is troubling," Mapp told the publication
BPC-157 mechanism: Targets localized tissue repair, tendon regeneration, angiogenesis, and gut mucosal healing with a strong preclinical safety record